Immunohistochemical study of Ki-67 (MIB-1), p53 protein, p21WAF1, and p27KIP1 expression in benign, atypical, and anaplastic meningiomas

Human Pathology

Volumn 32, Issue 9, 2001, Pages 970-975

  Amatya, Vishwa Jeet ^a   Takeshima, Yukio ^a   Sugiyama, Kazuhiko ^a   Kurisu, Kaoru ^a   Nishisaka, Takashi ^a   Fukuhara, Toshiyuki ^a   Inai, Kouki ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Immunohistochemistry; Meningioma; MIB 1; p21; p27; p53

Indexed keywords

KI 67 ANTIGEN; PROTEIN P21; PROTEIN P27; PROTEIN P53;

ADOLESCENT; ADULT; AGED; ANAPLASTIC CARCINOMA; ARTICLE; BENIGN TUMOR; CANCER GRADING; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; PROGNOSIS; PROTEIN EXPRESSION;

EID: 0034802792     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hupa.2001.27119     Document Type: Article

References (31)

1. Tumors of the central nervous system
2. Meningiomas
3. Meningioma grading an analysis of histological parameters
4. MIB-1 labeling indices in benign, aggressive, and malignant meningiomas: A study of 90 tumors
5. MIB-1 staining index and scoring of histologic features in meningioma. Indicators for the prediction of biologic potential and postoperative management
6. The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas
7. Prognostic significance of MIB-1, p53, and bcl-2 immunoreactivity in meningiomas
8. Postoperative residual tumor growth of meningioma can be predicted by MIB-1 immunohistochemistry
9. Role of p53 gene mutation in tumor aggressiveness of intracranial meningiomas
10. Correlation between histological grade, MIB-1, p53, and recurrence in 69 completely resected primary intracranial meningiomas with a 6 year mean follow-up
11. WAF1/CIP1 immunoreactivity and tumor micro-necrosis for recurrence of meningiomas
12. The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas
13. p53 and PCNA expression in benign, atypical and malignant meningiomas
14. Cancer cell cycles
15. Cell-cycle inhibitor p27/KIP1 expression in non-astrocytic and non oligodendrocytic human nervous system tumors
16. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27
17. High level expression of p27(KIP1) and cyclin D1 in some human breast cancer cells: Inverse correlation between the expression of p27(KIP1) and degree of malignancy in human breast and colorectal cancers
18. p27 expression and gastric carcinoma
19. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas
20. p27/KIP1 expression in human astrocytic gliomas
21. Proliferative potential of recurrent intracranial meningiomas as evaluated by labelling indices of BUdR and Ki-67, and tumour doubling time
22. Proliferating cell nuclear antigen (PCNA) and nucleolar organizer regions (NORs) in benign, atypical and malignant meningiomas
23. The significance of nucleolar organizer region (AgNOR) score in predicting meningioma recurrence
24. Morphometrical analysis of nucleolin immunohistochemistry, in meningiomas
25. Detection of p53 gene mutations in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products
26. Mutations of the p53 tumor suppressor gene in neoplasms of the human nervous system
27. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases
28. p21WAF1 immunohistochemical expression in breast carcinoma: Correlations with clinicopathological data, estrogen receptor status, MIB-1 expression, p53 gene and protein alterations and relapse-free survival
29. The clinical significance of p21 (WAF1/CIP-1) and p53 expression in pancreatic adenocarcinoma
30. WAF1/CIP1 expression in primary lung adenocarcinomas: Heterogeneous expression in tumor tissues and correlation with p53 expression and proliferative activities
31. Increased levels of p21WAF1/Cip1 in human brain tumors